Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma — Stella

Home/Brain Injuries/

View on ClinicalTrials.gov

Recruiting

Back to Brain Injuries trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Grady Health System, Atlanta, Georgia

Key details

Sponsor

Emory University

Collaborators

Abbott

Enrollment target

~350 participants

Started

May 2025

Primary completion

June 2026

Age range

18 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.